A Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network, Refer2Quit Trial
This clinical trial studies how well a referral system within the Children’s Hospital of Philadelphia Primary Care Network (Refer2Quit) works in connecting household members who smoke to smoking treatment and helps them quit smoking. Secondhand smoke (SHS) exposure among children worsens and/or increases the risk of sudden infant death syndrome, acute respiratory infections, chronic respiratory diseases, such as asthma, and lung cancer in adulthood. SHS exposure is a particularly serious public health problem for underserved populations and those who are socioeconomically disadvantaged, with nearly 7 in 10 non-Hispanic Black children exposed. Routinely delivered tobacco intervention to parents and family members would provide a major health benefit to the nation, in that tobacco use leads to 480,000 preventable deaths and $300 billion in tobacco attributable costs annually in the United States. Refer2Quit is a clinical decision support system that asks parents/caregivers about tobacco use via survey and captures when there are household members not at the visit or who did not complete the survey who smoke and gets permission to contact them to offer smoking cessation treatments. Refer2Quit may be able to lessen the harms of tobacco exposure on children, who are uniquely vulnerable, by treating household members who smoke with evidence-based treatments.